by Jordana Choucair | Dec 23, 2021 | Life Sciences
The FDA authorized Pfizer Inc.’s Paxlovid for high-risk patients 12 and older, making it the first antiviral pill to treat COVID-19 in the United States. Even so, it will likely be months before the pills are widely available. Jeff Zients, coordinator of the...
by Jordana Choucair | Dec 23, 2021 | D.C. News
The Supreme Court said it will fast-track a review of the Biden administration’s COVID-19 vaccination rules for private employers and health care workers, with oral arguments set for January 7. The mandates are still working their way through the lower courts,...
by Jordana Choucair | Dec 23, 2021 | Access & Coverage
The Biden administration announced that, thus far, a record 13.6 million people have enrolled in health coverage for 2022 on the ACA marketplaces. The previous high was 12.7 million in 2016. Health officials cited increased subsidies and outreach for the increase in...
by Jordana Choucair | Dec 21, 2021 | Public Health/Prevention
Omicron is now considered the most dominant COVID-19 variant, comprising 73 percent of new COVID-19 infections last week in the U.S. The new CDC estimates underscore just how rapidly it has spread across the U.S. As of a week prior, December 11, it was only detected...
by Jordana Choucair | Dec 21, 2021 | Mental Health
The U.S. Department of Health and Human Services (HHS) announced $282 million in additional funding to transition a nationwide suicide prevention hotline from its 10-digit number to three digits: 988. The funding includes more money to help states staff up existing...
Recent Comments